Newsroom
Strive to Deliver Breakthroughs
Cambridge, MA, Rotterdam, NL, Shanghai, CN — February 4, 2025 Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceuti...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN — January 10, 2025 Harbour BioMed (HKEX: 02142, the “Company”), a global biophar...
View moreCambridge, MA, Rotterdam, NL, Suzhou, CN — November 14, 2024 Harbour BioMed (the "Company”; HKEX: 02142), a global biopharmaceuti...
View moreCambridge, MA, Rotterdam, NL, Suzhou, CN – November 8, 2024 Harbour BioMed (the "Company”; HKEX: 02142), a global biopharmaceutic...
View moreCambridge, MA, Rotterdam, NL, Suzhou, CN — October 9, 2024 Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical...
View moreCambridge, MA, Rotterdam, NL, Suzhou, CN — September 14, 2024 Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceuti...
View moreHarbour BioMed (“HBM”, or the "Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and c...
View moreCambridge, MA, Rotterdam, NL, Suzhou, CN — July 25, 2024 Harbour BioMed (the "Company”; HKEX: 02142), a global biopharmaceutical ...
View moreCambridge, MA, Rotterdam, NL, Suzhou, CN – July 19, 2024 Harbour BioMed (the "Company”; HKEX: 02142), a global biopharmaceutical ...
View moreCambridge, MA, Rotterdam, NL, Suzhou, CN – June 27, 2024 Harbour BioMed (the "Company”; HKEX: 02142), a global biopharmaceutical ...
View more